Pharmacokinetics and Relative Bioavailability Study

NCT01521767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: tolterodine tartrate
DRUG: tolterodine tartrate
DRUG: tolterodine tartrate
DRUG: tolterodine tartrate
DRUG: tolterodine tartrate

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.